O	0	10	Expression	Expression	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	19	CD154	CD154	NN	B-NP
O	20	22	on	on	IN	B-PP
B-Cancer	23	28	renal	renal	JJ	B-NP
I-Cancer	29	33	cell	cell	NN	I-NP
I-Cancer	34	44	carcinomas	carcinoma	NNS	I-NP
O	45	48	and	and	CC	O
O	49	55	effect	effect	NN	B-NP
O	56	58	on	on	IN	B-PP
B-Cell	59	63	cell	cell	NN	B-NP
O	64	77	proliferation	proliferation	NN	I-NP
O	77	78	,	,	,	O
O	79	87	motility	motility	NN	B-NP
O	88	91	and	and	CC	I-NP
O	92	100	platelet	platelet	NN	I-NP
O	100	101	-	-	HYPH	O
O	101	111	activating	activate	VBG	B-VP
O	112	118	factor	factor	NN	B-NP
O	119	128	synthesis	synthesis	NN	I-NP
O	128	129	.	.	.	O

O	131	135	CD40	CD40	NN	B-NP
O	136	146	activation	activation	NN	I-NP
O	147	149	by	by	IN	B-PP
O	150	155	CD154	CD154	NN	B-NP
O	156	159	may	may	MD	B-VP
O	160	167	trigger	trigger	VB	I-VP
O	168	175	diverse	diverse	JJ	B-NP
B-Cell	176	184	cellular	cellular	JJ	I-NP
O	185	194	responses	response	NNS	I-NP
O	194	195	,	,	,	O
O	196	203	ranging	range	VBG	B-VP
O	204	208	from	from	IN	B-PP
O	209	222	proliferation	proliferation	NN	B-NP
O	223	226	and	and	CC	O
O	227	242	differentiation	differentiation	NN	B-NP
O	243	245	to	to	TO	B-PP
O	246	252	growth	growth	NN	B-NP
O	253	264	suppression	suppression	NN	I-NP
O	265	268	and	and	CC	O
B-Cell	269	273	cell	cell	NN	B-NP
O	274	279	death	death	NN	I-NP
O	279	280	,	,	,	O
O	281	283	in	in	IN	B-PP
O	284	290	normal	normal	JJ	B-NP
O	291	294	and	and	CC	I-NP
B-Cell	295	304	malignant	malignant	JJ	I-NP
I-Cell	305	310	cells	cell	NNS	I-NP
O	310	311	.	.	.	O

O	312	319	However	However	RB	B-ADVP
O	319	320	,	,	,	O
O	321	324	the	the	DT	B-NP
O	325	341	pathophysiologic	pathophysiologic	JJ	I-NP
O	342	346	role	role	NN	I-NP
O	347	349	of	of	IN	B-PP
O	350	355	CD154	CD154	NN	B-NP
O	356	365	expressed	express	VBN	B-VP
O	366	368	by	by	IN	B-PP
B-Cell	369	374	tumor	tumor	NN	B-NP
I-Cell	375	380	cells	cell	NNS	I-NP
O	381	388	remains	remain	VBZ	B-VP
O	389	396	unclear	unclear	JJ	B-ADJP
O	396	397	.	.	.	O

O	398	400	We	We	PRP	B-NP
O	401	405	have	have	VBP	B-VP
O	406	418	investigated	investigate	VBN	I-VP
O	419	422	the	the	DT	B-NP
O	423	433	expression	expression	NN	I-NP
O	434	436	of	of	IN	B-PP
O	437	440	the	the	DT	B-NP
O	441	445	CD40	CD40	NN	I-NP
O	445	446	-	-	HYPH	I-NP
O	446	451	CD154	CD154	NN	I-NP
O	452	458	system	system	NN	I-NP
O	459	461	in	in	IN	B-PP
O	462	464	24	24	CD	B-NP
O	465	472	primary	primary	JJ	I-NP
B-Cell	473	481	cultures	culture	NNS	I-NP
O	482	489	derived	derive	VBN	B-VP
O	490	494	from	from	IN	B-PP
B-Cancer	495	500	renal	renal	JJ	B-NP
I-Cancer	501	505	cell	cell	NN	I-NP
I-Cancer	506	516	carcinomas	carcinoma	NNS	I-NP
O	516	517	,	,	,	O
O	518	521	its	its	PRP$	B-NP
O	522	533	correlation	correlation	NN	I-NP
O	534	538	with	with	IN	B-PP
B-Cancer	539	544	tumor	tumor	NN	B-NP
O	545	550	stage	stage	NN	I-NP
O	551	554	and	and	CC	O
O	555	558	its	its	PRP$	B-NP
O	559	568	potential	potential	JJ	I-NP
O	569	579	functional	functional	JJ	I-NP
O	580	592	significance	significance	NN	I-NP
O	592	593	.	.	.	O

O	594	596	We	We	PRP	B-NP
O	597	602	found	find	VBD	B-VP
O	603	615	coexpression	coexpression	NN	B-NP
O	616	618	of	of	IN	B-PP
O	619	623	CD40	CD40	NN	B-NP
O	624	627	and	and	CC	I-NP
O	628	633	CD154	CD154	NN	I-NP
O	634	636	in	in	IN	B-PP
O	637	641	most	most	JJS	B-NP
O	642	644	of	of	IN	B-PP
O	645	648	the	the	DT	B-NP
B-Cell	649	654	renal	renal	JJ	I-NP
I-Cell	655	664	carcinoma	carcinoma	NN	I-NP
I-Cell	665	669	cell	cell	NN	I-NP
I-Cell	670	675	lines	line	NNS	I-NP
O	675	676	.	.	.	O

O	677	682	CD154	CD154	NN	B-NP
O	682	683	,	,	,	O
O	684	687	but	but	CC	O
O	688	691	not	not	RB	O
O	692	696	CD40	CD40	NN	B-NP
O	697	707	expression	expression	NN	I-NP
O	707	708	,	,	,	O
O	709	722	significantly	significantly	RB	B-VP
O	723	733	correlated	correlate	VBD	I-VP
O	734	738	with	with	IN	B-PP
B-Cancer	739	744	tumor	tumor	NN	B-NP
O	745	750	stage	stage	NN	I-NP
O	750	751	.	.	.	O

O	752	760	Moreover	Moreover	RB	B-ADVP
O	760	761	,	,	,	O
B-Cell	762	767	renal	renal	JJ	B-NP
I-Cell	768	777	carcinoma	carcinoma	NN	I-NP
I-Cell	778	782	cell	cell	NN	I-NP
I-Cell	783	788	lines	line	NNS	I-NP
O	789	793	also	also	RB	B-ADVP
O	794	802	released	release	VBD	B-VP
O	803	806	the	the	DT	B-NP
O	807	814	soluble	soluble	JJ	I-NP
O	815	819	form	form	NN	I-NP
O	820	822	of	of	IN	B-PP
O	823	828	CD154	CD154	NN	B-NP
O	829	833	into	into	IN	B-PP
O	834	837	the	the	DT	B-NP
B-Organism_substance	838	849	supernatant	supernatant	NN	I-NP
O	849	850	.	.	.	O

O	851	855	CD40	CD40	NN	B-NP
O	856	866	engagement	engagement	NN	I-NP
O	867	869	by	by	IN	B-PP
O	870	875	CD154	CD154	NN	B-NP
O	876	879	did	do	VBD	B-VP
O	880	883	not	not	RB	I-VP
O	884	890	affect	affect	VB	I-VP
O	891	900	apoptosis	apoptosis	NN	B-NP
O	901	903	or	or	CC	I-NP
O	904	912	survival	survival	NN	I-NP
O	912	913	.	.	.	O

O	914	916	On	On	IN	B-PP
O	917	920	the	the	DT	B-NP
O	921	929	contrary	contrary	NN	I-NP
O	929	930	,	,	,	O
O	931	936	CD154	CD154	NN	B-NP
O	937	947	stimulated	stimulate	VBD	B-VP
B-Cell	948	952	cell	cell	NN	B-NP
O	953	966	proliferation	proliferation	NN	I-NP
O	966	967	,	,	,	O
O	968	976	motility	motility	NN	B-NP
O	977	980	and	and	CC	I-NP
O	981	991	production	production	NN	I-NP
O	992	994	of	of	IN	B-PP
O	995	998	PAF	PAF	NN	B-NP
O	998	999	,	,	,	O
O	1000	1001	a	a	DT	B-NP
O	1002	1014	phospholipid	phospholipid	NN	I-NP
O	1015	1023	mediator	mediator	NN	I-NP
O	1024	1026	of	of	IN	B-PP
O	1027	1039	inflammation	inflammation	NN	B-NP
O	1040	1044	with	with	IN	B-PP
O	1045	1055	angiogenic	angiogenic	JJ	B-NP
O	1056	1066	properties	property	NNS	I-NP
O	1066	1067	.	.	.	O

O	1068	1079	Furthermore	Furthermore	RB	B-ADVP
O	1079	1080	,	,	,	O
O	1081	1084	the	the	DT	B-NP
B-Cell	1085	1090	renal	renal	JJ	I-NP
I-Cell	1091	1100	carcinoma	carcinoma	NN	I-NP
I-Cell	1101	1105	cell	cell	NN	I-NP
I-Cell	1106	1111	lines	line	NNS	I-NP
O	1112	1121	expressed	express	VBD	B-VP
O	1122	1125	PAF	PAF	NN	B-NP
O	1125	1126	-	-	HYPH	B-NP
O	1126	1127	R	R	NN	I-NP
O	1127	1128	.	.	.	O

O	1129	1137	Blockade	Blockade	NN	B-NP
O	1138	1140	of	of	IN	B-PP
O	1141	1144	PAF	PAF	NN	B-NP
O	1144	1145	-	-	HYPH	B-NP
O	1145	1146	R	R	NN	I-NP
O	1147	1149	by	by	IN	B-PP
O	1150	1153	WEB	WEB	NN	B-NP
O	1153	1154	-	-	HYPH	O
O	1154	1158	2170	2170	CD	B-NP
O	1158	1159	,	,	,	O
O	1160	1161	a	a	DT	B-NP
O	1162	1165	PAF	PAF	NN	I-NP
O	1165	1166	-	-	HYPH	I-NP
O	1166	1167	R	R	NN	I-NP
O	1168	1178	antagonist	antagonist	NN	I-NP
O	1178	1179	,	,	,	O
O	1180	1189	abolished	abolish	VBD	B-VP
O	1190	1193	the	the	DT	B-NP
O	1194	1199	CD154	CD154	NN	I-NP
O	1199	1200	-	-	HYPH	B-NP
O	1200	1209	dependent	dependent	JJ	I-NP
O	1210	1218	motility	motility	NN	I-NP
O	1218	1219	,	,	,	O
O	1220	1230	indicating	indicate	VBG	B-VP
O	1231	1232	a	a	DT	B-NP
O	1233	1237	role	role	NN	I-NP
O	1238	1241	for	for	IN	B-PP
O	1242	1245	PAF	PAF	NN	B-NP
O	1246	1257	synthesized	synthesize	VBN	B-VP
O	1258	1263	after	after	IN	B-PP
O	1264	1269	CD154	CD154	NN	B-NP
O	1270	1281	stimulation	stimulation	NN	I-NP
O	1282	1284	in	in	IN	B-PP
B-Cell	1285	1290	renal	renal	JJ	B-NP
I-Cell	1291	1300	carcinoma	carcinoma	NN	I-NP
I-Cell	1301	1305	cell	cell	NN	I-NP
O	1306	1314	motility	motility	NN	I-NP
O	1314	1315	.	.	.	O

O	1316	1318	In	In	IN	B-PP
O	1319	1329	conclusion	conclusion	NN	B-NP
O	1329	1330	,	,	,	O
O	1331	1335	this	this	DT	B-NP
O	1336	1341	study	study	NN	I-NP
O	1342	1352	identifies	identify	VBZ	B-VP
O	1353	1356	new	new	JJ	B-NP
O	1357	1367	functional	functional	JJ	I-NP
O	1368	1378	properties	property	NNS	I-NP
O	1379	1382	for	for	IN	B-PP
O	1383	1388	CD154	CD154	NN	B-NP
O	1388	1389	,	,	,	O
O	1390	1395	which	which	WDT	B-NP
O	1396	1399	are	be	VBP	B-VP
O	1400	1411	potentially	potentially	RB	B-ADJP
O	1412	1420	relevant	relevant	JJ	I-ADJP
O	1421	1424	for	for	IN	B-PP
O	1425	1428	the	the	DT	B-NP
O	1429	1435	growth	growth	NN	I-NP
O	1436	1439	and	and	CC	I-NP
O	1440	1453	dissemination	dissemination	NN	I-NP
O	1454	1456	of	of	IN	B-PP
B-Cell	1457	1462	renal	renal	JJ	B-NP
I-Cell	1463	1472	carcinoma	carcinoma	NN	I-NP
I-Cell	1473	1478	cells	cell	NNS	I-NP
O	1478	1479	.	.	.	O

